The COPD Pipeline XXXI.
作者信息
Gross Nicholas
机构信息
Stritch-Loyola School of Medicine, Maywood, Illinois (Emeritus Professor).
出版信息
Chronic Obstr Pulm Dis. 2016 Apr 18;3(2):589-593. doi: 10.15326/jcopdf.3.2.2016.0140.
Abstract
摘要
相似文献
1
The COPD Pipeline XXXI.慢性阻塞性肺疾病药物研发进展第三十一期
Chronic Obstr Pulm Dis. 2016 Apr 18;3(2):589-593. doi: 10.15326/jcopdf.3.2.2016.0140.
2
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD.正在开发用于治疗 COPD 的吸入型 PI3Kδ 抑制剂 GSK2269557 的安全性、药代动力学和剂量反应特征。
Pulm Pharmacol Ther. 2017 Oct;46:69-77. doi: 10.1016/j.pupt.2017.08.008. Epub 2017 Aug 17.
3
The COPD Pipeline XXIX.慢性阻塞性肺疾病（COPD）研发管线二十九。
Chronic Obstr Pulm Dis. 2015 Oct 20;2(4):370-374. doi: 10.15326/jcopdf.2.4.2015.0163.
4
The COPD Pipeline XXXII.慢性阻塞性肺疾病研发管线XXXII。
Chronic Obstr Pulm Dis. 2016 Jul 14;3(3):688-692. doi: 10.15326/jcopdf.3.3.2016.0150.
5
Moracin M inhibits airway inflammation by interrupting the JNK/c-Jun and NF-κB pathways in vitro and in vivo.桑色素M通过在体内外阻断JNK/c-Jun和NF-κB信号通路来抑制气道炎症。
Eur J Pharmacol. 2016 Jul 15;783:64-72. doi: 10.1016/j.ejphar.2016.04.055. Epub 2016 Apr 29.
6
Moracin M inhibits lipopolysaccharide-induced inflammatory responses in nucleus pulposus cells via regulating PI3K/Akt/mTOR phosphorylation.美商鞣花酸 M 通过调控 PI3K/Akt/mTOR 磷酸化抑制髓核细胞中脂多糖诱导的炎症反应。
Int Immunopharmacol. 2018 May;58:80-86. doi: 10.1016/j.intimp.2018.03.015. Epub 2018 Mar 17.
7
Pharmacokinetics, Excretion, and Mass Balance of [ C]-Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men.在健康男性中单次微 tracer 静脉内剂量（同时吸入剂量）或口服贝他福他林后，[ C]-贝他福他林的药代动力学、排泄和物料平衡。
Clin Pharmacol Drug Dev. 2018 Nov;7(8):901-910. doi: 10.1002/cpdd.616. Epub 2018 Sep 19.
8
Potential Moracin M Prodrugs Strongly Attenuate Airway Inflammation .潜在的桑色素M前药可显著减轻气道炎症。
Biomol Ther (Seoul). 2020 Jul 1;28(4):344-353. doi: 10.4062/biomolther.2019.212.
9
Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β-adrenoceptor agonist (MABA) molecule.新型吸入型双功能毒蕈碱型乙酰胆碱受体拮抗剂/β-肾上腺素能受体激动剂（MABA）化合物 LAS190792 的药理学临床前特征。
Pulm Pharmacol Ther. 2017 Oct;46:1-10. doi: 10.1016/j.pupt.2017.07.003. Epub 2017 Jul 17.
10
Effect of Double Bond Position on 2-Phenyl-benzofuran Antioxidants: A Comparative Study of Moracin C and Iso-Moracin C.双键位置对 2-苯基苯并呋喃类抗氧化剂的影响：桑辛素 C 和异桑辛素 C 的比较研究。
Molecules. 2018 Mar 24;23(4):754. doi: 10.3390/molecules23040754.
本文引用的文献
1
Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.毒蕈碱拮抗剂和β2激动剂GSK961081（巴替芬特罗）在中重度慢性阻塞性肺疾病患者中的群体药代动力学和药效学：一项随机试验的子研究
Drugs R D. 2015 Sep;15(3):281-91. doi: 10.1007/s40268-015-0104-x.
2
Evaluation of WO2013136076: two crystalline forms of the phosphatidylinositol 3-kinase-δ inhibitor RV-1729.WO2013136076的评估：磷脂酰肌醇3-激酶δ抑制剂RV-1729的两种晶型
Expert Opin Ther Pat. 2014 Apr;24(4):471-5. doi: 10.1517/13543776.2014.865725. Epub 2013 Nov 27.
3
Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.口服曲前列尼尔单药治疗肺动脉高压的疗效和安全性：一项随机对照试验。
Circulation. 2013 Feb 5;127(5):624-33. doi: 10.1161/CIRCULATIONAHA.112.124388. Epub 2013 Jan 10.
4
Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor.Moracin M 来源于桑白皮，是一种天然的磷酸二酯酶-4 抑制剂。
Bioorg Med Chem Lett. 2012 May 1;22(9):3261-4. doi: 10.1016/j.bmcl.2012.03.026. Epub 2012 Mar 21.
5
A cystic fibrosis allele encoding missense mutations in both nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator.一种囊性纤维化等位基因，其在囊性纤维化跨膜传导调节因子的两个核苷酸结合结构域中编码错义突变。
Hum Mutat. 1992;1(3):204-10. doi: 10.1002/humu.1380010305.
Zotero 插件